Emma R Woodward

Summary

Affiliation: Birmingham Women's Hospital
Country: UK

Publications

  1. pmc Parity and breast cancer risk among BRCA1 and BRCA2 mutation carriers
    Antonis C Antoniou
    CR UK Genetic Epidemiology Unit, Strangeways Research Laboratory, Department of Public Health and Primary Care, Worts Causeway, University of Cambridge, Cambridge, CB1 8RN, UK
    Breast Cancer Res 8:R72. 2006
  2. pmc Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: risks of breast/ovarian cancer quoted should reflect the cancer burden in the family
    D Gareth Evans
    Academic Unit of Medical Genetics and Regional Genetics Service, St Mary s Hospital Manchester M13 0JH, UK
    BMC Cancer 8:155. 2008
  3. ncbi request reprint Familial non-syndromic clear cell renal cell carcinoma
    Emma R Woodward
    Clinical Genetics Unit, Birmingham Women s Hospital, Metchley Park Road, Edgbaston, Birmingham, B15 2TG, UK
    Curr Mol Med 4:843-8. 2004
  4. ncbi request reprint Annual surveillance by CA125 and transvaginal ultrasound for ovarian cancer in both high-risk and population risk women is ineffective
    E R Woodward
    West Midlands Regional Genetics Service, Birmingham Women s Hospital, Edgbaston, Birmingham, UK
    BJOG 114:1500-9. 2007
  5. doi request reprint Germline SDHB mutations and familial renal cell carcinoma
    Christopher Ricketts
    Cancer Research UK Renal Molecular Oncology Group, Department of Medical and Molecular Genetics, University of Birmingham School of Medicine, Edgbaston, Birmingham, UK
    J Natl Cancer Inst 100:1260-2. 2008
  6. pmc Genome-wide CpG island methylation analysis implicates novel genes in the pathogenesis of renal cell carcinoma
    Christopher J Ricketts
    Centre for Rare Diseases and Personalized Medicine, University of Birmingham, Birmingham, UK
    Epigenetics 7:278-90. 2012
  7. ncbi request reprint VHL mutation analysis in patients with isolated central nervous system haemangioblastoma
    Emma R Woodward
    Cancer Research UK Renal Molecular Oncology Group, Department of Medical and Molecular Genetics, University of Birmingham, Institute of Biomedical Research, Edgbaston, Birmingham, UK
    Brain 130:836-42. 2007
  8. doi request reprint UBE2QL1 is disrupted by a constitutional translocation associated with renal tumor predisposition and is a novel candidate renal tumor suppressor gene
    Naomi C Wake
    Centre for Rare Diseases and Personalised Medicine, School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
    Hum Mutat 34:1650-61. 2013
  9. ncbi request reprint Genotype-phenotype correlations in von Hippel-Lindau disease
    Kai Ren Ong
    Department of Clinical Genetics, Birmingham Women s Hospital, Edgbaston, Birmingham, United Kingdom
    Hum Mutat 28:143-9. 2007
  10. doi request reprint Familial non-VHL clear cell (conventional) renal cell carcinoma: clinical features, segregation analysis, and mutation analysis of FLCN
    Emma R Woodward
    Cancer Research UK Renal Molecular Oncology Group and Department of Medical and Molecular Genetics, University of Birmingham and West Midlands Regional Genetics Service, Birmingham Women s Hospital, United Kingdom
    Clin Cancer Res 14:5925-30. 2008

Collaborators

Detail Information

Publications11

  1. pmc Parity and breast cancer risk among BRCA1 and BRCA2 mutation carriers
    Antonis C Antoniou
    CR UK Genetic Epidemiology Unit, Strangeways Research Laboratory, Department of Public Health and Primary Care, Worts Causeway, University of Cambridge, Cambridge, CB1 8RN, UK
    Breast Cancer Res 8:R72. 2006
    ..However, their effects among BRCA1 and BRCA2 mutation carriers is still under debate. We used retrospective data on BRCA1 and BRCA2 mutation carriers from the UK to assess the effects of parity-related variables on breast cancer risk...
  2. pmc Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: risks of breast/ovarian cancer quoted should reflect the cancer burden in the family
    D Gareth Evans
    Academic Unit of Medical Genetics and Regional Genetics Service, St Mary s Hospital Manchester M13 0JH, UK
    BMC Cancer 8:155. 2008
    ..However, considerable controversy exists regarding the cancer risks in women who test positive for the family mutation...
  3. ncbi request reprint Familial non-syndromic clear cell renal cell carcinoma
    Emma R Woodward
    Clinical Genetics Unit, Birmingham Women s Hospital, Metchley Park Road, Edgbaston, Birmingham, B15 2TG, UK
    Curr Mol Med 4:843-8. 2004
    ..Large scale collaborative linkage studies may provide a basis for the identification of familial non-syndromic clear cell RCC susceptibility gene(s)...
  4. ncbi request reprint Annual surveillance by CA125 and transvaginal ultrasound for ovarian cancer in both high-risk and population risk women is ineffective
    E R Woodward
    West Midlands Regional Genetics Service, Birmingham Women s Hospital, Edgbaston, Birmingham, UK
    BJOG 114:1500-9. 2007
    ..To assess the efficacy of annual CA125 and transvaginal ultrasound (TVU) scan as surveillance for ovarian cancer...
  5. doi request reprint Germline SDHB mutations and familial renal cell carcinoma
    Christopher Ricketts
    Cancer Research UK Renal Molecular Oncology Group, Department of Medical and Molecular Genetics, University of Birmingham School of Medicine, Edgbaston, Birmingham, UK
    J Natl Cancer Inst 100:1260-2. 2008
    ....
  6. pmc Genome-wide CpG island methylation analysis implicates novel genes in the pathogenesis of renal cell carcinoma
    Christopher J Ricketts
    Centre for Rare Diseases and Personalized Medicine, University of Birmingham, Birmingham, UK
    Epigenetics 7:278-90. 2012
    ....
  7. ncbi request reprint VHL mutation analysis in patients with isolated central nervous system haemangioblastoma
    Emma R Woodward
    Cancer Research UK Renal Molecular Oncology Group, Department of Medical and Molecular Genetics, University of Birmingham, Institute of Biomedical Research, Edgbaston, Birmingham, UK
    Brain 130:836-42. 2007
    ....
  8. doi request reprint UBE2QL1 is disrupted by a constitutional translocation associated with renal tumor predisposition and is a novel candidate renal tumor suppressor gene
    Naomi C Wake
    Centre for Rare Diseases and Personalised Medicine, School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
    Hum Mutat 34:1650-61. 2013
    ..These findings suggest UBE2QL1 as a novel candidate renal tumor suppressor gene. ..
  9. ncbi request reprint Genotype-phenotype correlations in von Hippel-Lindau disease
    Kai Ren Ong
    Department of Clinical Genetics, Birmingham Women s Hospital, Edgbaston, Birmingham, United Kingdom
    Hum Mutat 28:143-9. 2007
    ..These results extend genotype-phenotype-protein structure correlations in VHL disease and provide a baseline for future chemoprevention studies in VHL disease...
  10. doi request reprint Familial non-VHL clear cell (conventional) renal cell carcinoma: clinical features, segregation analysis, and mutation analysis of FLCN
    Emma R Woodward
    Cancer Research UK Renal Molecular Oncology Group and Department of Medical and Molecular Genetics, University of Birmingham and West Midlands Regional Genetics Service, Birmingham Women s Hospital, United Kingdom
    Clin Cancer Res 14:5925-30. 2008
    ....
  11. ncbi request reprint Von Hippel-Lindau disease and endocrine tumour susceptibility
    Emma R Woodward
    Section of Medical and Molecular Genetics and Cancer Research UK Renal Molecular Oncology Group, University of Birmingham, Institute of Biomedical Research, Birmingham B15 2TT, UK
    Endocr Relat Cancer 13:415-25. 2006
    ..Recently, it has been suggested that an HIF-independent failure of developmental apoptosis is a common feature of all inherited phaeochromocytoma susceptibility syndromes...